Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aaron Wallace

Showing results (41-50 of 47) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 47 results.
Frontiers in Immunology|September 29, 2022
Mucosal nanobody IgA as inhalable and affordable prophylactic and therapeutic treatment against SARS-CoV-2 and emerging variantsQi Li, Fiachra Humphries, Roxie C Girardin, et al.
Vaccines|July 27, 2024
Factors Associated with Uptake of Routine Measles-Containing Vaccine Doses among Young Children, Oromia Regional State, Ethiopia, 2021Abyot Bekele Woyessa, Monica P Shah, Binyam Moges Azmeraye, et al.
Plos Neglected Tropical Diseases|November 9, 2007
National mass drug administration costs for lymphatic filariasis eliminationAnn S Goldman, Victoria H Guisinger, Moses Aikins, et al.
Nature Communications|August 23, 2020
A cross-reactive human IgA monoclonal antibody blocks SARS-CoV-2 spike-ACE2 interactionMonir Ejemel, Qi Li, Shurong Hou, et al.
Biorxiv : the Preprint Server for Biology|October 17, 2024
Antibody-Fab and -Fc features promote <i>Mycobacterium tuberculosis</i> restrictionPatricia S Grace, Joshua M Peters, Jaimie Sixsmith, et al.
Immunity|May 31, 2025
Antibody-Fab and -Fc features promote Mycobacterium tuberculosis restrictionPatricia S Grace, Joshua M Peters, Jaimie Sixsmith, et al.
Emerging Infectious Diseases|December 11, 2022
CDC's COVID-19 International Vaccine Implementation and Evaluation Program and Lessons from Earlier Vaccine IntroductionsHeidi M Soeters, Reena H Doshi, Monica Fleming, et al.
Pageof 5

Showing results (41-50 of 47) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 47 results.
Frontiers in Immunology|September 29, 2022
Mucosal nanobody IgA as inhalable and affordable prophylactic and therapeutic treatment against SARS-CoV-2 and emerging variantsQi Li, Fiachra Humphries, Roxie C Girardin, et al.
Vaccines|July 27, 2024
Factors Associated with Uptake of Routine Measles-Containing Vaccine Doses among Young Children, Oromia Regional State, Ethiopia, 2021Abyot Bekele Woyessa, Monica P Shah, Binyam Moges Azmeraye, et al.
Plos Neglected Tropical Diseases|November 9, 2007
National mass drug administration costs for lymphatic filariasis eliminationAnn S Goldman, Victoria H Guisinger, Moses Aikins, et al.
Nature Communications|August 23, 2020
A cross-reactive human IgA monoclonal antibody blocks SARS-CoV-2 spike-ACE2 interactionMonir Ejemel, Qi Li, Shurong Hou, et al.
Biorxiv : the Preprint Server for Biology|October 17, 2024
Antibody-Fab and -Fc features promote <i>Mycobacterium tuberculosis</i> restrictionPatricia S Grace, Joshua M Peters, Jaimie Sixsmith, et al.
Immunity|May 31, 2025
Antibody-Fab and -Fc features promote Mycobacterium tuberculosis restrictionPatricia S Grace, Joshua M Peters, Jaimie Sixsmith, et al.
Emerging Infectious Diseases|December 11, 2022
CDC's COVID-19 International Vaccine Implementation and Evaluation Program and Lessons from Earlier Vaccine IntroductionsHeidi M Soeters, Reena H Doshi, Monica Fleming, et al.
Pageof 5